Rani Therapeutics Holdings
Stock Forecast, Prediction & Price Target
Rani Therapeutics Holdings Financial Estimates
Rani Therapeutics Holdings Revenue Estimates
Rani Therapeutics Holdings EBITDA Estimates
Rani Therapeutics Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $2.71M N/A | $0 -100% | $0 0% | Avg: $4.37M Low: $4.37M High: $4.37M avg. 0% | Avg: $19.97M Low: $19.97M High: $19.97M avg. 356.14% | Avg: $40.88M Low: $40.88M High: $40.88M avg. 104.65% | Avg: $100.35M Low: $100.35M High: $100.35M avg. 145.47% |
Net Income
% change YoY
| $-53.08M N/A | $-63.34M -19.31% | $-33.97M 46.37% | Avg: $-31.23M Low: $-23.71M High: $-11.73M avg. 8.06% | Avg: $-28.36M Low: $-27.29M High: $-515.45K avg. 9.18% | Avg: $-5.10M Low: $-5.10M High: $-5.10M avg. 82.01% | Avg: $10.71M Low: $10.71M High: $10.71M avg. 310% |
EBITDA
% change YoY
| $-51.51M N/A | $-62.20M -20.75% | $-65.27M -4.94% | Avg: $-875.84K Low: $-875.84K High: $-875.84K avg. 98.65% | Avg: $-3.99M Low: $-3.99M High: $-3.99M avg. -356.14% | Avg: $-8.17M Low: $-8.17M High: $-8.17M avg. -104.65% | Avg: $-20.07M Low: $-20.07M High: $-20.07M avg. -145.47% |
EPS
% change YoY
| -$2.69 N/A | -$2.66 1.11% | -$1.33 50% | Avg: -$0.79 Low: -$0.93 High: -$0.46 avg. 40.57% | Avg: -$0.57 Low: -$1.07 High: -$0.02 avg. 27.62% | Avg: -$0.2 Low: -$0.2 High: -$0.2 avg. 65.03% | Avg: $0.42 Low: $0.42 High: $0.42 avg. 309.99% |
Operating Expenses
% change YoY
| $54.31M N/A | $63.45M 16.81% | $66.09M 4.17% | Avg: $23.23M Low: $23.23M High: $23.23M avg. -64.85% | Avg: $105.96M Low: $105.96M High: $105.96M avg. 356.14% | Avg: $216.87M Low: $216.87M High: $216.87M avg. 104.65% | Avg: $532.35M Low: $532.35M High: $532.35M avg. 145.47% |
FAQ
What is Rani Therapeutics Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 102.31% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -23.71M, average is -31.23M and high is -11.73M.
What is Rani Therapeutics Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 151.56% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $4.37M, average is $4.37M and high is $4.37M.
What is Rani Therapeutics Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 110.80% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.93, average is -$0.79 and high is $-0.46.
What is the best performing analyst?
In the last twelve months analysts have been covering Rani Therapeutics Holdings stock. The most successful analyst is Annabel Samimy.